Continuing the year’s strong IPO activity, Scribe Therapeutics Inc. priced an upsized offering at the high end of its price range, offering 8.6 million shares at $15 apiece for gross proceeds of about ...

Sprint Bioscience AB has entered into an agreement to use Lilly Tunelab, Eli Lilly and Co.’s AI-based drug discovery platform, to support work on its research portfolio.

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

New drug approvals, financings and deals were seen across the Asia-Pacific biotech sector this week, with China’s National ...

Clinical updates for biopharma and med tech, including data readouts and publications: Eli Lilly, Johnson & Johnson, Koya, Penumbra, Serenity, Xodus.

Apertura Gene Therapy LLC has announced its participation in a consortium selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) THRIVE program to develop gene ...

A single-cell transcriptomics study of the fetal-maternal tissue interface in preeclampsia at different stages of gestation provides new information about the distinct maternal and fetal cell ...

HCW Biologics Inc. has requested a type B (pre-IND) meeting with the FDA to discuss the development and regulatory strategy ...

Medtronic plc’s recent launch of the Viaverte basivertebral nerve ablation system and completion of the acquisition of SPR Therapeutics Inc. broadens its chronic pain offering and strengthens its ...

Global drug approvals through the first half (H1) of 2026 reached 261, the third-highest H1 total in BioWorld’s records ...

Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain penetration designed for the treatment of ...

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...